fda-authorizes-use-of-diabetes-drug-tirzepatide-for-weight-loss

FDA authorizes use of diabetes drug tirzepatide for weight loss

On:
In: Health

The Food and Drug Administration has authorized Zepbound, which is manufactured by Eli Lilly, approval to be prescribed as a weight-management treatment, paving the way for more people to gain access to the medication., Read More